$VUZI
Vuzix Corp Stock $vuzi

$vuzi Overview Financials Valuation SEC Filings Company Website

2014 Q1 Form 10-Q Financial Statement

#000114420414031190 Filed on May 15, 2014

Income Statement

Concept	2014 Q1	2013 Q1
Revenue	$798.4K	$739.2K
YoY Change	8.01%	-74.08%
Cost Of Revenue	$450.2K	$337.4K
YoY Change	33.45%	-80.59%
Gross Profit	$348.2K	$401.8K
YoY Change	-13.35%	-63.92%
Gross Profit Margin	43.61%	54.36%
Selling, General & Admin	$844.2K	$691.4K
YoY Change	22.09%	-31.9%
% of Gross Profit	242.47%	172.08%
Research & Development	$397.4K	$317.7K
YoY Change	25.1%	-22.75%
% of Gross Profit	114.15%	79.07%
Depreciation & Amortization	$99.71K	$98.35K
YoY Change	1.38%	-27.59%
% of Gross Profit	28.64%	24.48%
Operating Expenses	$1.341M	$1.107M
YoY Change	21.12%	-29.53%
Operating Profit	-$993.2K	-$705.7K
YoY Change	40.74%	54.05%
Interest Expense	$38.49K	$179.8K
YoY Change	-78.6%	-40.35%
% of Operating Profit
Other Income/Expense, Net	$2.505M	-$230.6K
YoY Change	-1186.21%	-37.57%
Pretax Income	$1.512M	-$936.3K
YoY Change	-261.48%	13.15%
Income Tax	$0.00	$0.00
% Of Pretax Income	0.0%
Net Earnings	$1.512M	-$936.3K
YoY Change	-261.48%	10.87%
Net Earnings / Revenue	189.36%	-126.67%
Basic Earnings Per Share	$0.15	-$0.26
Diluted Earnings Per Share	$0.13	-$0.26
COMMON SHARES
Basic Shares Outstanding	9.972M shares	3.537M shares
Diluted Shares Outstanding	11.52M shares	3.537M shares

Balance Sheet

Concept	2014 Q1	2013 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$300.0K	$500.0K
YoY Change	-40.0%	25.0%
Cash & Equivalents	$271.8K	$532.4K
Short-Term Investments
Other Short-Term Assets	$100.0K	$300.0K
YoY Change	-66.67%	200.0%
Inventory	$1.036M	$600.0K
Prepaid Expenses
Receivables	$187.8K	$200.0K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$1.560M	$1.700M
YoY Change	-8.22%	-45.95%
LONG-TERM ASSETS
Property, Plant & Equipment	$415.8K	$600.0K
YoY Change	-30.7%	-31.8%
Goodwill
YoY Change
Intangibles	$494.7K
YoY Change
Long-Term Investments
YoY Change
Other Assets		$200.0K
YoY Change
Total Long-Term Assets	$1.432M	$1.400M
YoY Change	2.26%	-11.52%
TOTAL ASSETS
Total Short-Term Assets	$1.560M	$1.700M
Total Long-Term Assets	$1.432M	$1.400M
Total Assets	$2.992M	$3.100M
YoY Change	-3.49%	-34.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.274M	$3.200M
YoY Change	-28.94%	-14.11%
Accrued Expenses	$540.6K	$800.0K
YoY Change	-32.43%	231.08%
Deferred Revenue
YoY Change
Short-Term Debt	$200.0K	$500.0K
YoY Change	-60.0%	25.0%
Long-Term Debt Due	$99.32K	$1.300M
YoY Change	-92.36%	-74.72%
Total Short-Term Liabilities	$3.397M	$6.600M
YoY Change	-48.54%	-33.52%
LONG-TERM LIABILITIES
Long-Term Debt	$168.3K	$1.700M
YoY Change	-90.1%	84.83%
Other Long-Term Liabilities	$8.400M	$1.800M
YoY Change	366.67%	20.0%
Total Long-Term Liabilities	$8.558M	$3.500M
YoY Change	144.52%	45.18%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.397M	$6.600M
Total Long-Term Liabilities	$8.558M	$3.500M
Total Liabilities	$11.95M	$10.10M
YoY Change	18.36%	-18.15%
SHAREHOLDERS EQUITY
Retained Earnings	-$34.78M
YoY Change
Common Stock	$10.24K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$8.963M	-$7.100M
YoY Change
Total Liabilities & Shareholders Equity	$2.992M	$3.100M
YoY Change	-3.49%	-34.43%

Cashflow Statement

Concept	2014 Q1	2013 Q1
OPERATING ACTIVITIES
Net Income	$1.512M	-$936.3K
YoY Change	-261.48%	10.87%
Depreciation, Depletion And Amortization	$99.71K	$98.35K
YoY Change	1.38%	-27.59%
Cash From Operating Activities	-$1.073M	-$259.0K
YoY Change	314.4%	-188.03%
INVESTING ACTIVITIES
Capital Expenditures	$57.01K	$9.051K
YoY Change	529.86%	-75.56%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$348.9K	-$27.17K
YoY Change	1184.04%	-39.66%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net	$55.50K	$119.4K
YoY Change	-53.54%
Cash From Financing Activities	$1.384M	$752.0K
YoY Change	84.02%	-394.56%
NET CHANGE
Cash From Operating Activities	-$1.073M	-$259.0K
Cash From Investing Activities	-$348.9K	-$27.17K
Cash From Financing Activities	$1.384M	$752.0K
Net Change In Cash	-$38.33K	$465.9K
YoY Change	-108.23%	-7707.32%
FREE CASH FLOW
Cash From Operating Activities	-$1.073M	-$259.0K
Capital Expenditures	$57.01K	$9.051K
Free Cash Flow	-$1.130M	-$268.1K
YoY Change	321.68%	-204.23%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	168342	USD
CY2013Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	170496	USD
CY2014Q1	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	14462	USD
CY2013Q4	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	16365	USD
CY2014Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	8558184	USD
CY2014Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	99320	USD
CY2013Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	99320	USD
CY2013Q1	us-gaap	Share Based Compensation ShareBasedCompensation	19347	USD
CY2014Q1	us-gaap	Common Stock Value CommonStockValue	10241	USD
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	9600	USD
CY2013Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	12239559	USD
CY2014Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	25807574	USD
CY2013Q4	us-gaap	Liabilities Liabilities	15900414	USD
CY2013Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	23244639	USD
CY2014Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-34780626	USD
CY2013Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-36292532	USD
CY2014Q1	us-gaap	Stockholders Equity StockholdersEquity	-8962811	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	-13038293	USD
CY2014Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2991878	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2862121	USD
CY2013Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	9051	USD
CY2014Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	57009	USD
CY2014Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	11305	USD
CY2013Q1	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	18371	USD
CY2014Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	5708	USD
CY2014Q1	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	8042	USD
CY2013Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	119447	USD
CY2014Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	55501	USD
CY2013	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	10146228	USD
CY2014Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	993150	USD
CY2014Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2273853	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	271812	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	310140	USD
CY2014Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	187790	USD
CY2013Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	214920	USD
CY2014Q1	us-gaap	Inventory Net InventoryNet	1035674	USD
CY2014Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2013Q4	us-gaap	Inventory Net InventoryNet	953627	USD
CY2014Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	64910	USD
CY2013Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	200936	USD
CY2014Q1	us-gaap	Assets Current AssetsCurrent	1560186	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	1679623	USD
CY2014Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	415805	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	446329	USD
CY2014Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	494741	USD
CY2013Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	495608	USD
CY2014Q1	us-gaap	Assets Assets	2991878	USD
CY2013Q4	us-gaap	Assets Assets	2862121	USD
CY2014Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	700000000	shares
CY2014Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10240745	shares
CY2014Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10240745	shares
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2420571	USD
CY2014Q1	us-gaap	Notes Payable NotesPayable	231444	USD
CY2013Q4	us-gaap	Notes Payable NotesPayable	278467	USD
CY2014Q1	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	21881	USD
CY2013Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	24670	USD
CY2014Q1	us-gaap	Customer Deposits Current CustomerDepositsCurrent	98368	USD
CY2013Q4	us-gaap	Customer Deposits Current CustomerDepositsCurrent	170777	USD
CY2014Q1	us-gaap	Interest Payable Current InterestPayableCurrent	44546	USD
CY2013Q4	us-gaap	Interest Payable Current InterestPayableCurrent	36935	USD
CY2014Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	540564	USD
CY2013Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	554264	USD
CY2014Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	86529	USD
CY2013Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	75851	USD
CY2014Q1	us-gaap	Liabilities Current LiabilitiesCurrent	3396505	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3660855	USD
CY2014Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	8363751	USD
CY2013Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	12035816	USD
CY2014Q1	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	11629	USD
CY2013Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	16882	USD
CY2014Q1	us-gaap	Liabilities Liabilities	11954689	USD
CY2014Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2014Q1	us-gaap	Share Based Compensation ShareBasedCompensation	19347	USD
CY2014Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2013Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2013Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2014Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2014Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	700000000	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9600453	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9600453	shares
CY2012	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	4747387	USD
CY2014Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-27130	USD
CY2013Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-38240	USD
CY2014Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	82047	USD
CY2013Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-20757	USD
CY2014Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-136026	USD
CY2013Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	304913	USD
CY2014Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-146719	USD
CY2013Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	8318	USD
CY2014Q1	us-gaap	Increase Decrease In Customer Deposits IncreaseDecreaseInCustomerDeposits	-72409	USD
CY2013Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	2942	USD
CY2014Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	10678	USD
CY2013Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	129422	USD
CY2014Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	0	USD
CY2013Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	130016	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-259003	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1073311	USD
CY2013Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	18121	USD
CY2013Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	250304	USD
CY2014Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	752047	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1383882	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	465872	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-38328	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	66554	USD
CY2013Q1	us-gaap	Interest Paid InterestPaid	-49826	USD
CY2013Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	-10754	USD
CY2014Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	643300	shares
CY2013Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	608661	USD
CY2014Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	649418	USD
CY2013Q1	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	130523	USD
CY2014Q1	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	149000	USD
CY2013Q1	us-gaap	Sales Revenue Net SalesRevenueNet	739184	USD
CY2014Q1	us-gaap	Sales Revenue Net SalesRevenueNet	798418	USD
CY2014Q1	us-gaap	Cost Of Goods Sold CostOfGoodsSold	390649	USD
CY2013Q1	us-gaap	Cost Of Revenue CostOfRevenue	337387	USD
CY2013Q1	us-gaap	Gross Profit GrossProfit	401797	USD
CY2014Q1	us-gaap	Gross Profit GrossProfit	348169	USD
CY2013Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	317695	USD
CY2014Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	397422	USD
CY2013Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	274743	USD
CY2014Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	364555	USD
CY2013Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	416686	USD
CY2014Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	479637	USD
CY2013Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	98348	USD
CY2014Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	99705	USD
CY2013Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-705675	USD
CY2014Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-993150	USD
CY2013Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-13070	USD
CY2014Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-3951	USD
CY2013Q1	us-gaap	Derivative Loss On Derivative DerivativeLossOnDerivative	14287	USD
CY2014Q1	us-gaap	Derivative Loss On Derivative DerivativeLossOnDerivative	-2575262	USD
CY2013Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	9728	USD
CY2014Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	6326	USD
CY2013Q1	us-gaap	Interest Expense InterestExpense	179842	USD
CY2014Q1	us-gaap	Interest Expense InterestExpense	38487	USD
CY2013Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-230623	USD
CY2014Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2505056	USD
CY2013Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-936298	USD
CY2014Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1511906	USD
CY2013Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2014Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2013Q1	us-gaap	Net Income Loss NetIncomeLoss	-936298	USD
CY2014Q1	us-gaap	Net Income Loss NetIncomeLoss	1511906	USD
CY2013Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.26
CY2014Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.15
CY2013Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.26
CY2014Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.13
CY2013Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3536865	shares
CY2014Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9972105	shares
CY2013Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3536865	shares
CY2014Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11517104	shares
CY2014Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1544999	shares
CY2014Q1	us-gaap	Inventory Raw Materials And Purchased Parts Net Of Reserves InventoryRawMaterialsAndPurchasedPartsNetOfReserves	1135446	USD
CY2013Q4	us-gaap	Inventory Raw Materials And Purchased Parts Net Of Reserves InventoryRawMaterialsAndPurchasedPartsNetOfReserves	1094250	USD
CY2014Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	135913	USD
CY2013Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	153065	USD
CY2014Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	463810	USD
CY2013Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	280279	USD
CY2014Q1	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	73845	USD
CY2014Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2909	USD
CY2013Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	91385	USD
CY2014Q1	vuzi	Accrued Compensation AccruedCompensation	409517	USD
CY2013Q4	vuzi	Accrued Compensation AccruedCompensation	360670	USD
CY2014Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	25000	USD
CY2013Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	69500	USD
CY2014Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	29293	USD
CY2013Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	31619	USD
CY2014Q1	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	0	USD
CY2013Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1090	USD
CY2013Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	31619	USD
CY2014Q1	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	26672	USD
CY2014Q1	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	24346	USD
CY2014Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	29293	USD
CY2013Q1	us-gaap	Depreciation Depreciation	98348	USD
CY2014Q1	us-gaap	Depreciation Depreciation	99705	USD
CY2013Q1	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	USD
CY2014Q1	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	USD
CY2013Q1	vuzi	Amortization Of Debt Discount Relating To Discontinued Opeartions AmortizationOfDebtDiscountRelatingToDiscontinuedOpeartions	9728	USD
CY2014Q1	vuzi	Amortization Of Debt Discount Relating To Discontinued Opeartions AmortizationOfDebtDiscountRelatingToDiscontinuedOpeartions	6326	USD
CY2013Q1	vuzi	Amortization Of Debt Issuance Costs AmortizationOfDebtIssuanceCosts	1244	USD
CY2014Q1	vuzi	Amortization Of Debt Issuance Costs AmortizationOfDebtIssuanceCosts	0	USD
CY2013Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	53520	USD
CY2014Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-13700	USD
CY2013Q1	us-gaap	Increase Decrease In Customer Deposits IncreaseDecreaseInCustomerDeposits	-3678	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-27172	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-348899	USD
CY2013Q1	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	800000	USD
CY2013Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	160439	USD
CY2014Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	532426	USD
CY2014Q1	us-gaap	Interest Paid InterestPaid	-32779	USD
CY2014Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	-10764	USD
CY2013Q1	vuzi	Discount Senior Convertible Debenture Attributed To Warrants DiscountSeniorConvertibleDebentureAttributedToWarrants	621012	USD
CY2014Q1	vuzi	Discount Senior Convertible Debenture Attributed To Warrants DiscountSeniorConvertibleDebentureAttributedToWarrants	0	USD
CY2013Q1	vuzi	Warrants Granted For Senior Convertible Debenture Issuance Costs WarrantsGrantedForSeniorConvertibleDebentureIssuanceCosts	66603	USD
CY2014Q1	vuzi	Warrants Granted For Senior Convertible Debenture Issuance Costs WarrantsGrantedForSeniorConvertibleDebentureIssuanceCosts	0	USD
CY2014Q1	us-gaap	Assets Fair Value Disclosure Recurring AssetsFairValueDisclosureRecurring	0	USD
CY2014Q1	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	0	USD
CY2014Q1	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	8363751	USD
CY2014Q1	us-gaap	Liabilities Fair Value Disclosure Recurring LiabilitiesFairValueDisclosureRecurring	8363751	USD
CY2014Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	8363751	USD
CY2013Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	12035816	USD
CY2014Q1	us-gaap	Long Term Debt LongTermDebt	267662	USD
CY2013Q4	us-gaap	Long Term Debt LongTermDebt	269816	USD
CY2014Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	99320	USD
CY2014Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	100064	USD
CY2014Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	68278	USD
CY2014Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0	USD
CY2014Q1	vuzi	Long Term Debt Maturities Repayments Of Principal After Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour	0	USD
CY2014Q1	us-gaap	Basis Of Accounting BasisOfAccounting	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN-TOP: 0px; TEXT-INDENT: 0in; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 0in" align="justify"><b>Note 1  Basis of Presentation</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;BACKGROUND-COLOR: transparent; MARGIN: 0pt 40.1pt 0pt 34.55pt; FONT: 10pt Times New Roman, Times, Serif"> <b> </b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN-TOP: 0px; TEXT-INDENT: 0.25in; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 0in" align="left">The accompanying unaudited Condensed Consolidated Financial Statements of Vuzix Corporation and Subsidiaries (“the Company") have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X of the Securities and Exchange Commission. Accordingly, the unaudited Condensed Consolidated Financial Statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. The condensed consolidated balance sheet as of December 31, 2013 was derived from the audited Consolidated Financial Statements in Form 10-K.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0.5in; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN-TOP: 0px; TEXT-INDENT: 0.25in; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 0in" align="left">The accompanying Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements of the Company as of December 31, 2013, as reported in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0.5in; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN-TOP: 0px; TEXT-INDENT: 0.25in; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 0in" align="left">The results of the Company’s operations for any interim period are not necessarily indicative of the results of the Company’s operations for any other interim period or for a full fiscal year.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2013Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	11405522	USD
CY2014Q1	vuzi	Federal And State Net Operating Loss Carryforwards FederalAndStateNetOperatingLossCarryforwards	28395033	USD
CY2014Q1	vuzi	Operating Loss Carryforwards Expiration Year OperatingLossCarryforwardsExpirationYear	2018
CY2013Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	7147775	shares
CY2014Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.72
CY2013Q4	vuzi	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerLimit	1.71
CY2013Q4	vuzi	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperLimit	17.50
CY2014Q1	vuzi	Share Based Compensation Arrangement By Share Based Payment Award Options Granted Exercise Price Range ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedExercisePriceRange	0
CY2014Q1	vuzi	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Balance ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitBalance	1.71
CY2014Q1	vuzi	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Balance ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitBalance	17.50
CY2014Q1	vuzi	Class Of Warrant Or Right Exercised In Period ClassOfWarrantOrRightExercisedInPeriod	-665000	shares
CY2014Q1	vuzi	Class Of Warrant Or Right Grants In Period ClassOfWarrantOrRightGrantsInPeriod	0	shares
CY2014Q1	vuzi	Class Of Warrant Or Right Expired In Period ClassOfWarrantOrRightExpiredInPeriod	57668	shares
CY2014Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	6425107	shares
CY2014Q1	vuzi	Class Of Warrant Or Right Outstanding Weighted Average Remaining Contractual Terms ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractualTerms	P4Y
CY2014Q1	invest	Investment Warrants Exercise Price InvestmentWarrantsExercisePrice	2.74
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	214518	shares
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	0	shares
CY2014Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	214518	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.72
CY2014Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2014Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	206791	shares
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	9.68
CY2014Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y7M6D
CY2013Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
CY2014Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
CY2014Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	69871	USD
CY2014Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P9M18D
CY2014Q1	us-gaap	Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear	33510	USD
CY2013Q1	us-gaap	Taxes Other TaxesOther	13696	USD
CY2014Q1	us-gaap	Taxes Other TaxesOther	21442	USD
CY2013Q1	us-gaap	Operating Expenses OperatingExpenses	1107472	USD
CY2014Q1	us-gaap	Operating Expenses OperatingExpenses	1341319	USD
CY2014Q1	dei	Document Type DocumentType	10-Q
CY2014Q1	dei	Amendment Flag AmendmentFlag	false
CY2014Q1	dei	Document Period End Date DocumentPeriodEndDate	2014-03-31
CY2014Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
CY2014Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2014Q1	dei	Trading Symbol TradingSymbol	VUZI
CY2014Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	10302641	shares
CY2014Q1	dei	Entity Registrant Name EntityRegistrantName	Vuzix Corp
CY2014Q1	us-gaap	Payments To Acquire Software PaymentsToAcquireSoftware	280585	USD
CY2013Q1	vuzi	Deferred Offering Costs Other DeferredOfferingCostsOther	43069	USD
CY2014Q1	vuzi	Deferred Offering Costs Other DeferredOfferingCostsOther	0	USD
CY2014Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001463972
CY2014Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2014Q1	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2014Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	699495	USD
CY2013Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	573967	USD
CY2013	us-gaap	Increase Decrease In Deferred Revenue And Customer Advances And Deposits IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits	39700	USD
CY2014Q1	us-gaap	Increase Decrease In Deferred Revenue And Customer Advances And Deposits IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits	52217	USD
CY2014Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1447425	USD
CY2013Q1	us-gaap	Payments To Acquire Software PaymentsToAcquireSoftware	0	USD
CY2013Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
CY2014Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	521146	USD
CY2013Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	240561	USD
CY2014Q1	vuzi	Share Based Compensation Shares Authorized Under Stock Option Plans Exercised In Period Exercise Price Range ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisedInPeriodExercisePriceRange	0
CY2014Q1	vuzi	Share Based Compensation Arrangement By Share Based Payment Award Options Expired And Forfeited Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredAndForfeitedExercisePrice	0
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	7727	shares
CY2014Q1	vuzi	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice	10.82
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P6Y4M24D
CY2014Q1	vuzi	Working Capital Deficit WorkingCapitalDeficit	1836319	USD
CY2014Q1	vuzi	Officers Compensation Payable Compounding Monthly Interest Rate OfficersCompensationPayableCompoundingMonthlyInterestRate	0.08	pure

Files In Submission

Name	View Source	Status
0001144204-14-031190-index-headers.html	Edgar Link	pending
0001144204-14-031190-index.html	Edgar Link	pending
0001144204-14-031190.txt	Edgar Link	pending
0001144204-14-031190-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v377702_10q.htm	Edgar Link	pending
v377702_ex31-1.htm	Edgar Link	pending
v377702_ex31-2.htm	Edgar Link	pending
v377702_ex32-1.htm	Edgar Link	pending
v377702_ex32-2.htm	Edgar Link	pending
vuzi-20140331.xml	Edgar Link	completed
vuzi-20140331.xsd	Edgar Link	pending
vuzi-20140331_cal.xml	Edgar Link	unprocessable
vuzi-20140331_def.xml	Edgar Link	unprocessable
vuzi-20140331_lab.xml	Edgar Link	unprocessable
vuzi-20140331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VUZI
Vuzix Corp Stock $vuzi

2014 Q1 Form 10-Q Financial Statement

#000114420414031190 Filed on May 15, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VUZI Vuzix Corp Stock $vuzi

2014 Q1 Form 10-Q Financial Statement

#000114420414031190 Filed on May 15, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VUZI
Vuzix Corp Stock $vuzi